跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,346 条关于
“EGFR mutation”
全部
9,346
临床试验
6,775
药物
277
机构
5
资讯
2,289
去年
Lunit and AstraZeneca to Present AI Model for EGFR Mutation Prediction in NSCLC at AACR 2025
去年
ctDNA Clearance Predicts Improved Outcomes in EGFR-Mutated NSCLC Treated with Icotinib
去年
Biocartis Achieves First IVDR Class C Companion Diagnostic Certification for EGFR Mutation Test in Europe
去年
BlossomHill Therapeutics Advances EGFR-Mutant NSCLC Treatment with First-in-Class OMNI-EGFR Inhibitor BH-30643
去年
Roswell Park Celebrates 20 Years of Precision Medicine in Mesothelioma Treatment
9个月前
ArriVent Initiates Pivotal Phase 3 ALPACCA Trial for Firmonertinib in EGFR PACC Mutant NSCLC
3个月前
RYBREVANT Plus LAZCLUZE Achieves Nearly 3.5-Year Median Overall Survival in Atypical EGFR-Mutated NSCLC
去年
CTC-Guided EGFR Inhibitor Therapy Achieves 14-Month Response in Metastatic Hepatocellular Carcinoma
去年
Novel Treatment Strategies Emerge for EGFR-Mutated NSCLC as Amivantamab Shows Promise
去年
Delta-Fly Pharma's DFP-14323 Phase III Trial Progresses with Afatinib Recommendation
第 1 页,共 229 页
上一页
下一页